Marvin Moser,James Sowers,Thomas Giles
Marvin Moser
During the meeting of the American Society of Hypertension in New York, NY, in May 2003, there was an opportunity to discuss management of hypertension in diabetic patients. The discussion was moderated by Dr. Marvin Moser of the Yale Unive...
The differences between ACE inhibitor-treated and calcium channel blocker-treated hypertensive patients [0.03%]
血管紧张素转换酶抑制剂与钙拮抗剂治疗高血压患者的差异
Gordon T McInnes
Gordon T McInnes
Large-scale outcome trials have demonstrated that blood pressure reduction with angiotensin-converting enzyme (ACE) inhibitors or calcium channel blockers (CCBs) is associated with reduced cardiovascular complications in hypertension. Compa...
Incidence of pedal edema formation with dihydropyridine calcium channel blockers: issues and practical significance [0.03%]
二氢吡啶类钙通道阻滞剂引起足部水肿的发病率及其实际意义
Matthew R Weir
Matthew R Weir
Dihydropyridine calcium channel blockers comprise a class of powerful, well-tolerated, and safe antihypertensive agents that are widely used either alone or as a key component of combination therapy for hypertension. Peripheral edema, parti...
Quality of life measured in a practice-based hypertension trial of an angiotensin receptor blocker [0.03%]
在实践基地的高血压试验中使用血管紧张素受体阻滞剂的生活质量评估研究
Michael A Weber,George L Bakris,Joel M Neutel et al.
Michael A Weber et al.
Effectiveness of antihypertensive treatment depends not only on drugs that avoid or minimize symptomatic side effects but also on therapy that has a positive effect on quality of life. This study assessed the effect on quality of life of a ...
Elpidoforos S Soteriades,Stefanos N Kales,Dimitrios Liarokapis et al.
Elpidoforos S Soteriades et al.
The authors evaluated blood pressure and antihypertensive medication use in 334 firefighters in an occupational medical surveillance program. Firefighters received written summaries of their examination results, including blood pressures, a...
Marvin Moser
Marvin Moser
The first hypertension trial comparing the effects of two fixed-dose combination therapy regimens on cardiovascular events: Avoiding Cardiovascular events through Combination therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) [0.03%]
治疗高血压比较两种固定剂量复方疗法对心血管事件影响的首个试验：ACCOMPLISH试验
Kenneth A Jamerson;Avoiding Cardiovascular events through Combination therapy in Patients Living with Systolic Hypertension Trial
Kenneth A Jamerson;Avoiding Cardiovascular events through Combination therapy in Patients Living with Systolic Hypertension Trial
Current recommendations for the treatment of hypertension clarify the need to achieve lower blood pressure levels in the general population (
Who should be treated with combination therapy as initial treatment for hypertension? [0.03%]
初始治疗高血压时，哪些人适合接受联合用药？
George L Bakris
George L Bakris
There is currently consensus regarding the need to initiate antihypertensive therapy with a combination of two agents from different antihypertensive classes in selected patients. This consensus extends to the need to bring blood pressure t...
Creating a combination antihypertensive regimen: what does the research show? [0.03%]
抗高血压药治疗方案的研究进展如何？
Michael A Weber
Michael A Weber
Major randomized clinical trials have demonstrated unquestionable clinical benefits of lowering blood pressure without establishing superiority of any specific antihypertensive medication. Most notably, these trials have indicated that a ma...
Thomas D Giles
Thomas D Giles
Recent hypertension guidelines recommend initiating antihypertensive therapy with a combination of two or more agents in patients whose blood pressure exceeds their appropriate blood pressure goal by 20/10 mm Hg. This recommendation is base...